Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00108238 · ClinicalTrials.gov registry record · Phase 4
Estrogen Alternatives Study
A Phase 4 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 4
- Development phase
NCT00108238 is a Phase 4 study that has completed, run by US Department of Veterans Affairs.
The verdict
NCT00108238, a Phase 4 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 4
- Development phase
Study Summary
Healthy postmenopausal women not currently taking hormone replacement or hormone modulating therapy take a 3-month course of estradiol/raloxifene/placebo to evaluate the effects of each on vascular function, as indicated by PET coronary flow reserve studies and brachial artery ultrasound, before and after use of the therapies. This is a randomized, placebo-controlled, blinded study.
Interventions
- DRUG Raloxifene
- DRUG Estradiol followed by progesterone
Trial Details
| Field | Value |
|---|---|
| Start Date | 2003-04 |
| Est. Completion | 2006-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00108238
The ClinicalTrials.gov registry entry for NCT00108238 describes a study currently listed as completed, categorized as Phase 4. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Raloxifene is the first listed.
NCT00108238 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00108238 about?
NCT00108238 is a clinical study titled "Estrogen Alternatives Study". Healthy postmenopausal women not currently taking hormone replacement or hormone modulating therapy take a 3-month course of estradiol/raloxifene/placebo to evaluate the effects of each on vascular function, as indicated by PET coronary flow reserve studies and brachial artery ultrasound, before and...
What is the current status of trial NCT00108238?
This trial is currently completed. It is a Phase 4 study. The study started on 2003-04. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00108238?
The interventions under investigation include: Raloxifene (DRUG), Estradiol followed by progesterone (DRUG).
Who is sponsoring clinical trial NCT00108238?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.